1. Home
  2. CUBI vs ARQT Comparison

CUBI vs ARQT Comparison

Compare CUBI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Customers Bancorp Inc

CUBI

Customers Bancorp Inc

HOLD

Current Price

$77.33

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$25.64

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUBI
ARQT
Founded
1994
2016
Country
United States
United States
Employees
869
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CUBI
ARQT
Price
$77.33
$25.64
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$85.00
$34.00
AVG Volume (30 Days)
320.5K
1.7M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
N/A
N/A
Revenue
N/A
$376,072,000.00
Revenue This Year
$24.95
$34.85
Revenue Next Year
$9.50
$29.39
P/E Ratio
$11.78
N/A
Revenue Growth
N/A
91.34
52 Week Low
$59.34
$13.06
52 Week High
$82.56
$31.77

Technical Indicators

Market Signals
Indicator
CUBI
ARQT
Relative Strength Index (RSI) 52.26 58.30
Support Level $71.61 $24.81
Resistance Level $79.19 $27.26
Average True Range (ATR) 2.06 1.10
MACD 0.16 -0.05
Stochastic Oscillator 48.69 40.78

Price Performance

Historical Comparison
CUBI
ARQT

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company conducting banking activities through its wholly owned subsidiary, Customers Bank. The Bank provides commercial and consumer customers the stability of a regulated financial institution supported by risk management. It serves commercial and corporate businesses nationwide, including healthcare, real estate, specialty finance, fund finance, technology and venture capital banking, mortgage finance and commercial equipment financing, and provides payments and treasury services. The Bank also serves consumers through its branch network, offering residential mortgages and personal loan and deposit products, including Banking-as-a-Service, with services delivered predominantly in Southeastern and Central Pennsylvania, New York, and other states.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: